Showing 1191-1200 of 4940 results for "".
Put Me in, Coach; I'm Ready!
https://practicaldermatology.com/topics/practice-management/put-me-in-coach-im-ready/21172/Coaching offers future-focused leaders an opportunity to give back to a profession they love and to a community of professional friends they respect and admire.Kythera's Kybella Approved; ASLMS Update
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-kythera-s-kybella-approved-aslms-update/18925/FDA Approves Kythera's Kybella (ATX-101 or deoxycholic acid) injection for reduction of sub mental fullness or double chin. ASLMS Recognizes women in device-based medicine (Women in Energy-based Devices). Deka and Syneron get new clearances. ASDS Launches Skin Cancer PSAs, and Foamix sells shares.The Importance of Skincare
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-importance-of-skincare/19035/Whether patients want lasers, injectables, Botox, or cosmeceuticals, they need guidance on proper skincare to prevent wrinkles and skin cancer, says Dina Anderson, MD, FAAD. Patients need to learn about antioxidants, free radicals, and the effects of smoking.SEO Playbook: On-Page Factors
https://practicaldermatology.com/topics/practice-management/seo-playbook-on-page-factors/18994/Internet marketing is constantly changing--especially when it comes to SEO. Learn how on-page factors like Content, HTML, and architecture affect SEO and the marketing value of your practice website.Google Maps: It's More Important Than You Think
https://practicaldermatology.com/topics/practice-management/google-maps-it-s-more-important-than-you-think/18997/An Ekwa Marketing education video (Ekwa.com). Google map results are important to provide your practice a page one listing for Google search results and provides a way for patients to find you easily. Google Map listings improve your SEO, too!DermwireTV — Valeant Ups Allergan Bid, Nestle Buys Injectables, and Allergan Makes Its Case
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-valeant-ups-allergan-bid-nestle-buys-injectables-and-allergan-makes-its-case/19128/BREAKING NEWS: Valeant has increased its offer for Allergan to $72 per share. Read more. Valeant sells the rights to its aesthetic injectables to Nestle, while Allergan touts physician support and challenges Valeant's business model. In this week's edition of DermWireTV, learn about Valeant's latesHeliocare in Practice
https://practicaldermatology.com/topics/practice-management/heliocare-in-practice/19220/Polypodium leucotomos extract, which is derived from a tropical fern, offers benefits to users by minimizing some of the damage to the skin caused by exposure to visible light—UVA and UVB radiation—as well as invisible infrared light. Vivian Bucay, MD, discusses its activity and its role as a dispenCritical Factors to Advancing Melanoma Diagnosis and Treatment
https://practicaldermatology.com/topics/skin-cancer-photoprotection/critical-factors-to-advancing-melanoma-diagnosis-and-treatment/22970/Dermatologists need to stay abreast of technologies for evaluation of lesions and ensure that medical oncologists within their referral network recognize the importance of clinical trials.Indoor Tanning Beds: The Dangers of Adolescent Tanning
https://practicaldermatology.com/topics/skin-cancer-photoprotection/indoor-tanning-beds-the-dangers-of-adolescent-tanning/22972/As research continues to shed light on the connection between UV exposure and skin cancer, greater efforts are required to inform the public and affect the legislative process.A State of Transition for EHRs
https://practicaldermatology.com/topics/practice-management/a-state-of-transition-for-ehrs/22953/As practitioners await the next step in the larger implementation of this technology, an emphasis on utility is more important than ever.